Advertisement

Boston Scientific Corporation BSX

Set alert

Price alert · BSX

All alert types
43.98 USD +2.00 +4.77%

As of Nov 2, 12:22 PM ET

Bid
43.98 × 800
Ask
43.99 × 400
41.90 Day range 44.21
39.57 52-week range 105.65
YTD
-53.87%
1 year
-56.33%
Open
42.07
Prev close
41.98
Mkt cap
63.75B
Vol
8.72M
Avg vol
19.60M
EPS
2.37
P/E
18.56
Div yield
0.00%
More statistics
Low
41.90
High
44.21
Forward P/E
13.16
Beta
0.57
Short ratio
2.17
Inst. own
94.93%
Dividend
0.00
Ex-div date
Earnings
Feb 3, 2027
50-d avg
44.94
200-d avg
56.78
1y target
51.53

5Y chart

Chart tools
Interval

Events in this range
  • Oct 22, 2025Earnings: 0.75; estimate 0.714; surprise 5.04%
  • Feb 4, 2026Earnings: 0.8; estimate 0.781; surprise 2.43%
  • Apr 22, 2026Earnings: 0.8; estimate 0.788; surprise 1.52%
  • Jul 29, 2026Earnings: 0.86; estimate 0.835; surprise 2.99%
  • Oct 28, 2026Earnings: 0.73; estimate 0.727; surprise 0.41%
  • Oct 29, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 29, 2026Rating: Bernstein · Outperform → Outperform
  • Oct 29, 2026Rating: Canaccord Genuity · Buy → Buy
  • Oct 29, 2026Downgrade: Jefferies · Buy → Hold
  • Oct 30, 2026Rating: Barclays · Equal-Weight → Equal-Weight
  • Oct 30, 2026Downgrade: TD Cowen · Buy → Hold
Signals (94)
NameDateAgo
SMA: BullishNov 2, 202612 hours ago
SMA: BearishOct 26, 20261 week ago
SMA: BullishOct 19, 20262 weeks ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishJul 27, 20263 months ago
MACD: Buy SignalJul 13, 20263 months ago
RSI: OversoldMay 25, 20265 months ago
RSI: OversoldMar 2, 20268 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BearishNov 17, 202511 months ago
SMA: BearishNov 17, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BullishOct 20, 20251 year ago
SMA: BearishSep 15, 20251 year ago
SMA: BearishSep 8, 20251 year ago
SMA: BullishAug 18, 20251 year ago
SMA: BearishAug 4, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 7, 20251 year ago
SMA: BullishJun 23, 20251 year ago
SMA: BearishJun 9, 20251 year ago
MACD: Sell SignalJun 2, 20251 year ago
MACD: Buy SignalMay 26, 20251 year ago
SMA: BullishApr 21, 20251 year ago
SMA: BullishApr 7, 20251 year ago
SMA: BearishMar 31, 20251 year ago
MACD: Sell SignalMar 10, 20251 year ago
SMA: BearishMar 3, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago
RSI: OverboughtJan 6, 20251 year ago
MACD: Sell SignalDec 16, 20241 year ago
MACD: Buy SignalNov 18, 20241 year ago
RSI: OverboughtNov 18, 20241 year ago
MACD: Sell SignalNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
MACD: Buy SignalNov 4, 20241 year ago
RSI: OverboughtNov 4, 20241 year ago
SMA: BearishOct 28, 20242 years ago
MACD: Sell SignalOct 28, 20242 years ago
MACD: Buy SignalSep 9, 20242 years ago
SMA: BullishAug 12, 20242 years ago
RSI: OverboughtAug 12, 20242 years ago
SMA: BearishJul 22, 20242 years ago
MACD: Sell SignalJul 1, 20242 years ago
SMA: BullishApr 22, 20242 years ago
SMA: BearishApr 15, 20242 years ago
RSI: OverboughtJan 8, 20242 years ago
MACD: Buy SignalNov 20, 20232 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BullishNov 13, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BearishNov 6, 20232 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BullishOct 30, 20233 years ago
SMA: BearishOct 9, 20233 years ago
SMA: BearishOct 2, 20233 years ago
SMA: BullishAug 28, 20233 years ago
SMA: BearishAug 14, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BullishJul 10, 20233 years ago
SMA: BearishJul 3, 20233 years ago
MACD: Sell SignalJul 3, 20233 years ago
SMA: BullishJun 12, 20233 years ago
MACD: Buy SignalJun 12, 20233 years ago
SMA: BearishJun 5, 20233 years ago
MACD: Sell SignalJun 5, 20233 years ago
SMA: BullishMay 29, 20233 years ago
SMA: BearishMay 22, 20233 years ago
RSI: OverboughtMay 8, 20233 years ago
RSI: OverboughtApr 10, 20233 years ago
MACD: Buy SignalMar 20, 20233 years ago
SMA: BullishMar 13, 20233 years ago
SMA: BearishMar 6, 20233 years ago
MACD: Sell SignalMar 6, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishOct 17, 20224 years ago
SMA: BullishOct 17, 20224 years ago
MACD: Buy SignalOct 17, 20224 years ago
MACD: Sell SignalOct 3, 20224 years ago
SMA: BearishSep 19, 20224 years ago
SMA: BearishSep 19, 20224 years ago
SMA: BullishSep 5, 20224 years ago
SMA: BearishAug 22, 20224 years ago
SMA: BullishAug 8, 20224 years ago
MACD: Buy SignalAug 1, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BullishMar 14, 20224 years ago
SMA: BearishMar 7, 20224 years ago
SMA: BullishFeb 21, 20224 years ago
SMA: BearishFeb 14, 20224 years ago

Key statistics

Market cap
60.78B
Enterprise value
74.17B
Trailing P/E
17.70
Forward P/E
13.16
PEG ratio
0.60
Price / sales
2.88
Price / book
2.43
EPS (TTM)
2.37
Beta
0.57
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
16.62%
Revenue (TTM)
21.07B
Revenue growth
1.40%
Free cash flow
0
Total cash
539.00M
Total debt
12.62B
Return on equity
14.32%
Shares outstanding
1.45B
Short % of float
2.81%
50-day average
44.94
200-day average
56.78

Analyst view

Consensus: buy

Buy
Price target (mean) 51.53 +17.2% upside
Target (low)
41.00
Target (mean)
51.53
Target (high)
78.00
Ratings (0m) 31 20 buy · 11 hold · 0 sell
  • Strong buy6
  • Buy14
  • Hold11
  • Sell0
  • Strong sell0

Next earnings

Feb 3, 2027

Expected Feb 3, 2027. Consensus EPS estimate 0.7756.

Earnings history

Financials — quick view

All financials
BSX Revenue — quarterly 5.44B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BSX Net income — quarterly 907.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BSX EPS — quarterly 0.62
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

BSX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 3, 2027Dec 30, 20260.79———
Oct 28, 2026Sep 30, 20260.7270.730.00+0.41%
Jul 29, 2026Jun 30, 20260.8350.86+0.03+2.99%
Apr 22, 2026Mar 31, 20260.7880.80+0.01+1.52%
Feb 4, 2026Dec 31, 20250.7810.80+0.02+2.43%
Oct 22, 2025Sep 30, 20250.7140.75+0.04+5.04%

Upgrades / downgrades

BSX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026TD CowendownBuyHold
Oct 30, 2026BarclaysmainEqual-WeightEqual-Weight
Oct 29, 2026JefferiesdownBuyHold
Oct 29, 2026Canaccord GenuitymainBuyBuy
Oct 29, 2026BernsteinmainOutperformOutperform
Oct 29, 2026RBC CapitalmainOutperformOutperform

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on BSX — it syncs with the Stock Master app.

Insider holders

BSX insider holders
InsiderRelationLatest transactionDateShares held
BRENNAN DANIEL JChief Financial OfficerSaleFeb 18, 2025225,808
BROWN VANCE RGeneral CounselStock Award(Grant)Feb 12, 202654,244
BUTCHER ARTHUR COfficerConversion of Exercise of derivative securityApr 30, 202677,115
CARRUTHERS WENDYOfficerSaleDec 1, 202429,308
FITZGERALD JOSEPH MICHAELOfficerStock Award(Grant)Feb 12, 2026219,141
LUDWIG EDWARD J.DirectorPurchaseJul 30, 202630,359

Institution ownership

BSX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.95%129,680,9165.44BJun 29, 2026
Vanguard Capital Management LLC6.70%97,087,5534.07BJun 29, 2026
State Street Corporation4.84%70,111,1962.94BJun 29, 2026
Primecap Management Company3.49%50,520,9142.12BJun 29, 2026
FMR, LLC3.15%45,702,8451.92BJun 29, 2026
Geode Capital Management, LLC2.31%33,440,1021.40BJun 29, 2026

Fund ownership

BSX fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.26%47,181,2841.98BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.66%38,518,7881.62BJun 29, 2026
VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund2.13%30,831,0391.29BJun 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.33%19,294,226809.20MAug 30, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%19,310,588809.89MSep 29, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.23%17,894,864750.51MSep 29, 2026
Advertisement